Mankind Pharma Schedules Q3 FY26 Earnings Call for February 3, 2026
Mankind Pharma Limited has scheduled an investor conference call for February 3, 2026, at 6:00 PM IST to discuss Q3 and 9M FY26 financial results. The one-hour earnings call will feature seven senior management executives including Vice Chairman Rajeev Juneja and CEO Sheetal Arora. The company has provided multiple dial-in options including universal numbers and international toll-free access for USA, UK, Singapore, and Hong Kong. This regulatory announcement was communicated to stock exchanges on January 16, 2026, in compliance with SEBI regulations.
*this image is generated using AI for illustrative purposes only.
Mankind Pharma has announced its quarterly investor conference call to discuss Q3 and 9M FY26 financial results. The pharmaceutical company informed stock exchanges about the scheduled earnings call on January 16, 2026, in compliance with SEBI regulations.
Earnings Call Schedule
The investor conference call is scheduled for February 3, 2026, and will run for one hour from 6:00 PM to 7:00 PM IST. The call aims to provide insights into the company's business performance and financial results for the third quarter and nine-month period of FY26.
| Call Details: | Information |
|---|---|
| Date: | Tuesday, February 3, 2026 |
| Time: | 6:00 PM – 7:00 PM IST |
| Duration: | 1 hour |
| Purpose: | Q3 & 9M FY26 results discussion |
Dial-in Information
The company has provided comprehensive access options for investors and analysts to participate in the earnings call. Multiple dial-in numbers are available to accommodate both domestic and international participants.
| Access Type: | Contact Details |
|---|---|
| Universal Dial-in: | +91 22 6280 1102, +91 22 7115 8003 |
| USA Toll-Free: | 18667462133 |
| UK Toll-Free: | 08081011573 |
| Singapore Toll-Free: | 8001012045 |
| Hong Kong Toll-Free: | 800964448 |
Participants can pre-register for the call to avoid wait times and dial in directly without waiting for operator assistance.
Management Participation
The earnings call will feature comprehensive representation from Mankind Pharma's senior leadership team. Seven key executives will participate to provide detailed insights into the company's performance and address investor queries.
Senior Management Participants:
- Mr. Rajeev Juneja – Vice Chairman & Managing Director
- Mr. Sheetal Arora – Chief Executive Officer & Whole Time Director
- Mr. Arjun Juneja - Chief Operating Officer
- Mr. Sudipta Roy – Senior President – Sales & Marketing
- Mr. Ashutosh Dhawan – Global Chief Financial Officer
- Mr. Prakash Agarwal – President (Strategy)
- Mr. Abhishek Agarwal – Head - Investor Relations & AVP - Strategy
Contact Information
For additional details regarding the earnings call, investors can reach out through multiple channels. The company has provided both internal and external contact points for investor relations support.
| Contact Type: | Details |
|---|---|
| Company Contact: | Abhishek Agarwal, Email: Investor.relations@mankindpharma.com , Phone: 011-46846700 |
| PR Contact: | Adfactors PR - Snighter Albuquerque/Smit Shah, Mobile: +91 9870789596 |
The announcement was formally communicated to BSE Limited and National Stock Exchange of India Limited under Regulation 30 and 51 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary & Compliance Officer Hitesh Kumar Jain signed the regulatory filing, and the details are also available on the company's official website at www.mankindpharma.com .
Historical Stock Returns for Mankind Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.07% | -5.90% | -0.16% | -19.33% | -18.40% | +52.95% |
18
